RHOFADE FDA approval date

The FDA approved RHOFADE on 18 Jan 2017.

FDA approval date
18 Jan 2017

Drug identity has not yet been verified against registry records

Also recorded as OXYMETAZOLINE HYDROCHLORIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2017-01-18DayRHOFADEFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA208552", "applicant_as_listed_by_fda": "MAYNE PHARMA", "brand_names": ["RHOFADE"], "active_ingredients": ["OXYMETAZOLINE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20170118", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026